Stocks
Funds
Screener
Sectors
Watchlists
ZTS

ZTS - Zoetis Inc Stock Price, Fair Value and News

$164.65+1.13 (+0.69%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

ZTS Price Action

Last 7 days

-7.6%


Last 30 days

-6.3%


Last 90 days

-14.5%


Trailing 12 Months

-15.4%

ZTS RSI Chart

ZTS Valuation

Market Cap

74.3B

Price/Earnings (Trailing)

30.57

Price/Sales (Trailing)

8.12

EV/EBITDA

20.92

Price/Free Cashflow

32.19

ZTS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ZTS Fundamentals

ZTS Revenue

Revenue (TTM)

9.2B

Rev. Growth (Yr)

11.02%

Rev. Growth (Qtr)

1.14%

ZTS Earnings

Earnings (TTM)

2.4B

Earnings Growth (Yr)

14.43%

Earnings Growth (Qtr)

9.29%

ZTS Profitability

EBT Margin

33.34%

Return on Equity

46.43%

Return on Assets

16.93%

Free Cashflow Yield

3.11%

ZTS Investor Care

Dividend Yield

1.01%

Dividend/Share (TTM)

1.67

Buy Backs (1Y)

1.73%

Diluted EPS (TTM)

5.32

ZTS Alerts

  • 1 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20248.7B8.9B9.2B0
20238.1B8.2B8.4B8.5B
20227.9B8.0B8.0B8.1B
20217.0B7.4B7.6B7.8B
20206.3B6.3B6.5B6.7B
20195.9B6.0B6.2B6.3B
20185.4B5.6B5.7B5.8B
20175.0B5.0B5.1B5.3B
20164.8B4.9B4.9B4.9B
20154.8B4.8B4.8B4.8B
20144.6B4.6B4.7B4.8B
20134.4B4.4B4.5B4.6B
20124.3B4.3B4.3B4.3B
20113.7B3.9B4.1B4.2B
20100003.6B
ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
 CEO
 WEBSITEzoetis.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES13800

Zoetis Inc Frequently Asked Questions


What is the ticker symbol for Zoetis Inc? What does ZTS stand for in stocks?

ZTS is the stock ticker symbol of Zoetis Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Zoetis Inc (ZTS)?

As of Fri Dec 20 2024, market cap of Zoetis Inc is 74.28 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ZTS stock?

You can check ZTS's fair value in chart for subscribers.

Is Zoetis Inc a good stock to buy?

The fair value guage provides a quick view whether ZTS is over valued or under valued. Whether Zoetis Inc is cheap or expensive depends on the assumptions which impact Zoetis Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZTS.

What is Zoetis Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, ZTS's PE ratio (Price to Earnings) is 30.57 and Price to Sales (PS) ratio is 8.12. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZTS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Zoetis Inc's stock?

In the past 10 years, Zoetis Inc has provided 0.144 (multiply by 100 for percentage) rate of return.